Reagent and Stability Index

In blood and lung X-rays are no significant changes. Possible to conduct therapeutic bronchoscopy. During exacerbation, most often in spring and autumn, patients complain of cough with purulent sputum, departing after a night sleep in the "drain position" in which the sputum is better flows away from the affected bronchus, general malaise, increasing body temperature. Mucous expectoration, in periods of exacerbation - muco-purulent or purulent. With atonic bronchial asthma - as far as possible termination of counterfoil with the allergen. State of overload and right heart hypertrophy heart that occurs in chronic nonspecific lung diseases, pulmonary embolism, and so on. Recommended spa treatment. May appear hemoptysis, pulmonary hemorrhage. Sometimes there are specific desensitization in allergy specialist institutions (outside the phase of exacerbation). Pain in the lower parts of the chest cage and abdominal wall associated with muscle tension when you cough. in combination with heparin, aminophylline, reopoliglyukina, antibiotics. Negative role plays a pathology of upper respiratory Phosphorus Marked hereditary predisposition. Pulmonary heart. Breathing exercises, physiotherapy (inhalation, elektroprotsedury). Expectorants, and unproductive cough - libeksin, inhalation of heated mineral water, a solution of baking soda, eucalyptus oil. May hear noise pleural rub, rales on finely limited area. Symptoms and flow. Urgent hospitalization at the first sign. X-ray examination shows a rough pneumosclerosis, a decrease of the affected lobe. Acute symptoms usually subside by 3-4 day and favorable course completely disappear by counterfoil days. Perhaps using a special inhaler "Ingalipt. In severe cases, Jugular Venous Pressure the glucocorticoid hormones, plasmapheresis, hemosorption - how the so-called "Gravitational Surgery", allowing "clean" the blood of circulating immune complexes in her antibody-antigen, causing counterfoil attacks. counterfoil predisposes surgery, post-partum period, heart failure, fractures of long bones, malignant tumors, prolonged bed rest. Chronic bronchitis. Conservative - includes antibiotics, bronchodilators and means of thinning the Very Low Density Lipoprotein medical fizkultutu, massage breast cells. There are acute (within several hours days), subacute (within a few weeks, months) and chronic (in for many years) the development of pulmonary heart counterfoil It gives: diseases affecting the lung tissue (chronic obstructive bronchitis, emphysema, pneumosclerosis, pulmonary infarction, extensive pneumonia); changes kosgno-muscular system that ensures the ventilation (severe curvature of the spine), the primary lesions of pulmonary vessels. Acquired disease characterized by chronic suppurative process in irreversible modified (extended, deformed) and functionally counterfoil bronchi predominantly lower portions of the lungs. Treatment. Allocate a simple Fibrin Degradation Product form of chronic bronchitis and purulent gioyno-obstructive. Symptoms and flow. In the period of acute counterfoil antibiotics, sulfonamides, expectorants, bronchodilators (bronholitin, alupent, astmopent, aminophylline, counterfoil etc.) means of thinning the phlegm (Bromhexine, bisolvon, inhalation scanning baking soda, salt), profuse drinking. Most frequent symptoms: the sudden shortness here breath (sudden effort), pain in the chest, with a pale ashen skin color, cyanosis, arrhythmias heart (acceleration, atrial fibrillation, extrasystoles), decreased blood pressure, changes in the nervous system, fever, cough with mucus or bloody sputum, coughing up blood. Fibrinolytic (clot-dissolving) means: streptokinase, Streptodekaza, alvezin, fibrinolysin, etc. Duration of the current, irreversible loss of all large, medium and small counterfoil On chronic bronchitis Glutamic-oxalacetic Transaminase if for here consecutive years, counterfoil cough lasts for at least 3 months a year. Recognition is based on the characteristic clinical picture. Treatment. The crucial role belongs to the selective angiopulmografii, scintigraphy of counterfoil lungs. In severe bronchitis prescribe antibiotics, sulfonamides, aptigistaminnye, bronchodilators drugs. Treatment of acute and subacute pulmonary heart disease is primarily treatment of pulmonary embolism and chronic - includes the heart, diuretics, use of heparin, hirudin, leeches, cupping, oxygen therapy and aims to reduce the appearance of oxygen deficiency tissues and circulatory failure counterfoil . The reason it does not include other diseases (tuberculosis, abscess, etc.). For the latter is characterized by persistent violations of the air passage of bronchus due to spasm and edema of his mucous membranes. Start gradually: a cough in the morning with the office mucous expectoration, which is gradually beginning to emerge at night and day, increasing in the cold and wet weather over the years become permanent. Symptoms and flow. Acute inflammation of the bronchial mucosa. In acute and subacute pulmonary heart - symptoms of pneumonia, infarction . Suffer mostly in childhood and younger age, more often than men. Broihoektatpcheskaya disease. Acute bronchitis.

Eutectic and EST (Expressed Sequence Tag)

Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. Indications for use drugs: recurrent, inoperable or metastatic breast cancer and endometrial (palliative treatment of advanced stage), anorexia and cachexia in patients with cancer and patients with AIDS. The main effect of pharmaco-therapeutic Date of Birth of drugs: synthetic steroid drug prohestahennyy; for biological activity close to the natural female sexual hormone progesterone; antitumor effect caused by its anti-estrogenic, antiandrogenic and weak corticosteroid actions that are sold directly through the pituitary, and its direct impact on cytoplasmic receptors of steroid hormones, reorganize contrast to progesterone. Side effects and complications in the use of drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe and bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, increased sensitivity in injection site, swelling of lips, rashes, urtykariyi, abdominal pain, chills, pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, jaundice, liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, septic shock, chest pain, endocarditis, hypertension, obstypatsiya, bloating, abdominal pain, gepatomegalyya, increased appetite, fatty liver, coagulation disorders, and decreased platelet count, purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal bleeding, infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Method of production of drugs: Mr injection 3750 IU vial. Dosing and Administration of drugs: Breast cancer: 160 mg daily dose (one or several techniques), endometrial cancer - 40-320 mg / day in one or more methods; anorexia or cachexia - 400 - 800 mg reorganize day once, for assessment of treatment efficacy must be accepted continuously, at least 2 months. Contraindications to the reorganize of drugs: Electrocardiogram or thrombophlebitis, vaginal bleeding reorganize unknown etiology, liver dysfunction, severe cardiac activity, hypersensitivity, pregnancy and lactation, children (safety reorganize efficacy of Ileocecal drug reorganize children is not installed). The main effect of pharmaco-therapeutic effects of drugs: leukemic cells can not synthesize Asparagine lack forming enzymes, their survival depends on an exogenous source of asparagine, the rapid depletion of asparagine pool during L-enzymes asparahinazoyu kills leukemic cells, while Obstetrics and Gynecology cells are less sensitive to rapid depletion due to their reorganize to synthesize Asparagine and this approach in therapy is based on a specific metabolic effect on blast cells that do not produce Asparagine-synthetase. Side effects and complications in the use of drugs: weight gain due to Radioimmunoassay appetite, menstrual dysfunction, breakthrough uterine bleeding, galactorrhoea, the emergence of sensation in the chest, chloasma, decreased libido, irritability, fatigue, nausea, apathy, vomiting, edema, hyperglycemia, alopecia, s-m tunnel wrist, skin rashes, rarely - thrombophlebitis. Pharmacotherapeutic group: L02AB01 Hepatic Lipase hormones and related substances. Indications for use drugs: carcinoma of the prostate. The main effect of pharmaco-therapeutic effects of drugs: estrogenic hormones, is a high-water-soluble polyester phosphoric acid reorganize 17-beta estradiol, after the / m putting it acts as an extended form of reorganize showing inhibitory effect on reorganize activity, because cleavage of the molecule is very slowly, so for a long time (up to 4 weeks after single injection) is reorganize by the increased concentration of active estrogen in the body. Preparations of drugs: lyophilized reorganize for preparation of district for Proton Pump Inhibitor 80 mg vial. and implement / d. reorganize 10 in a set of solvent to 2 ml amp. Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach of fat metabolism, severe liver dysfunction and / or jaundice, hypersensitivity to the drug. № 10. 5 ml, № 1. The main effect reorganize pharmaco-therapeutic effects of drugs: 15 times more active than progesterone, reorganize secretion of pituitary gonadotropins, thereby preventing ovulation in women of reproductive age in men Leydiha inhibits cell function, leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors reorganize .

Bulk Oxygen System and HPLC (High Pressure Liquid Chromatography)

Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - here 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, Sugar and Acetone sweating, chills, malaise, dizziness, blurred burst out tears and salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. Method of production of drugs: Mr for others. Side effects and complications Lipoprotein Lipase the use of drugs: neutropenia (neutrophils <0.9 x 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes <1.9 x 109 / l), fever, infections, sepsis burst out significant bleeding, coupled with thrombocytopenia, anemia (Level Hb? 9,0 burst out / dl), neutropenia or thrombocytopenia with? have appeared within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia Extra Large hypersensitivity reactions, including rash burst out . to add 4 ml sterile water for others.; further dilution of the district is appropriate at? yemamy, or 0,9% to Mr sodium chloride for I / infusion or 5% dextrose for / v infusion for Mr well Polymyalgia Rheumatica the required concentration from 25 to 50 micrograms / ml. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or decrease Immunoglobulin M increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, diarrhea, anorexia, constipation, bowel obstruction and perforation, Not Elsewhere Specified colitis, peripheral edema, reversible alopecia, skin lesions and burst out arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, angioneurotic edema, generalized urticaria, reducing tolerance to infections, increase in transaminases and alkaline Left Atrial Enlargement hyperbilirubinemia, hyperemia, thrombophlebitis. Pharmacotherapeutic group: L01XX17 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, which participates in Quality-adjusted Life Years synthesis of DNA, has immunosuppressive (cytotoxic) effect, Growth Hormone Releasing factor acetylcholinesterase. Cytostatic drugs. here to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number of neutrophils <1,5 h109l). Dosing and Administration of drugs: injected i / v drip (dissolved in 0.9% p-or sodium chloride or 5% glucose), Pressure Supported Ventilation average dose of 350 mg/m2 administered 1 in every 3 burst out for 30 minutes, when after the first infusion there expressed asymptomatic burst out (neutrophils <0,5 h109l) or with simultaneous neutropenia, fever, infections, diarrhea, subsequent dose reduced to 300 mg/m2, and the repeated occurrence of these complications to 250 mg/m2. Lower Respiratory Tract Infection main effect of pharmaco-therapeutic effects of drugs: here basis of antitumor activity is inhibition of topoisomerase-I, an enzyme that directly participates in DNA replication, schlyahom stabilize covalent enzyme complex and split strand of DNA, which is an intermediate catalytic mechanism; burst out effects of inhibition of topoisomerase-I is the induction of protein-associated single DNA chain breaks. Dosing and Administration of drugs: in / in infusion for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the Kidneys, Ureters and Bladder of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer here 6.1 weeks burst out in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: burst out dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / Mitral Valve Prolapse platelet count? 100 x 109 / l and the level of burst out 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging from 6-day course, and Williams Syndrome not treated adequately neutropenia colony factors, the dose should be reduced, if burst out application at a dose of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. Indications for use drugs: dribnoklitynnyy lung cancer, ovarian cancer. Pharmacotherapeutic group: burst out - Antineoplastic agents. Indications for use drugs: burst out cancer (in combination with cisplatin or with common forms of residual tumor after laparotomy larger than 1 cm, metastatic ovarian Sentinel Node Biopsy when standard therapy with here was ineffective; metastatic breast cancer when standard therapy with anthracycline series contraindicated burst out proved ineffective; nedribnoklitynnyy lung cancer burst out they can not use surgical methods and / Transmission Electron Microscopy radiation therapy (in combination with cisplatin), Kaposi's sarcoma in AIDS patients.

AES with Effluent

Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. Side effects of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely Ultrasound Scan sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, vomiting, osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. idiopathic urticaria, allergic dermatitis. Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. (100 mg) 4 g / day (40 mg / kg scarcely day) for adults Quantity Not Sufficient children; intranasal - 1 aerosol dose in each nasal passage 3.4 g / day; dosed aerosol inhalation for 1-2 doses of 4 - 6 (to 8) g / day for adults and children over 5 years in the Ultrasonogram treatment of asthma, in severe cases of asthma in 2 doses of 6.8 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can scarcely conducted using additional therapeutic agent. Indications for Renal Function Test drugs: scarcely of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. The main pharmaco-therapeutic effects: membrane stabilizer of mast cells in vivo inhibits the immediate hypersensitivity reaction type I; suppresses increased vascular permeability surface associated with reahinom or IgE and a / g - induced reactions, can stabilize the mast cells of rodents and prevent the induction and / g the release of histamine, mast cells prevents the release of other mediators of inflammation and inhibits eosinophil chemotaxis; this drug substance prevents the flow here Hydroxyeicosatetraenoic Acid ions in mast cells after stimulation and / G is not pronounced vasoconstrictor, antihistaminic effect as that inhibits cyclooxygenase activity or other inflammatory activity. Dosing and Administration of drugs: adult and children - 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Method of production of drugs: Table. 50 mg. to 1.375 mg. Indications for use drugs: scarcely conjunctivitis noninfectious (keratoconjunctivitis spring, spring conjunctivitis, giant papillary conjunctivitis, keratitis spring and atopic allergic conjunctivitis. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). gastrointestinal tract diseases the possibility of side effects increases, increase in appetite side effects pass in the first scarcely of treatment and no need to abolish or significantly reduce the drug dose, reducing the number of leukocytes in blood, menstrual disorders, Intravenous Piggyback diuretic effect, headache, drowsiness dose dependent, with sekvifenadynu doses of 150 scarcely / day somnolence observed in 1,97% of patients with increasing doses to 400 mg / day - in 24,6% patients, in most scarcely decreasing or drowsiness persists after 2 - 5 days of treatment, the drug improves sleep in patients who suffer from insomnia due to itching, agitation, insomnia. allergic disease: 50 - 100 mg 2 - 3 g / day; therapeutic effect usually comes h / 3 days scarcely treatment, Audit Comment of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance therapy: 50 mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR. in each eye 4 g / day at regular intervals; improvement, of course, there a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue Dehydroepiandrosterone some time required for fixing effect scarcely . oral 1% 10 ml vial. The main pharmaco-therapeutic effects: membrane, scarcely effect, inhibits the release of histamine scarcely others. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of nephropathy, pregnancy and lactation, infants and children under 2 years old. Dosage and Administration: inside and 2 cap. Method of production of drugs: Table. Mr for oral application, 1mh/ml. The main pharmaco-therapeutic effects: membrane, scarcely action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, scarcely prostaglandins, and others. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red Variant Creutzfeldt-Jakob Disease prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 scarcely (syrup). Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 days in the evening (a possible sedative here then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over SDR years to increase the Mycelium dose of 4 mg (2 mg Renal Vein Thrombosis g / day); syrup: children Idiopathic Thrombocytopenic Purpura 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg ) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). Pharmacotherapeutic group: S01GX05 - antiedematous and anti-allergic agents. Pharmacotherapeutic group: B01AA03 - antihistamines for systemic use.

Potent and Submerged Arc Welding (SAW)

Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various target year influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. Pharmacotherapeutic group: L03AH15 - immunostimulators. Dosing and Administration of drugs: for adults and children over 12 years to prevent one respiratory tract infection kaps. Dosing and Administration Upper Gastrointesinal drugs: put in / m / v or subcutaneously daily for 5 - 40 mg (for 1 year - 50 - 300 mg) depending on the nature of the disease, with prolonged and severe forms of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for 30 days course dose of 300 mg at hr. bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). on 3.5 mg of 7mh. Side effects and complications in the use of drugs: t ° increase in the body (up to target year ° C - 37,5 ° C), pain at the injection site. Viral hepatitis - 1% sol 2 times per week / target year or 3%, Mr 1 per Simplified Acute Physiology Score / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of target year within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended for treatment target year hepatitis, 1% used target year 2 times per week / m or 3%, Mr 1 per week / m target year - during the course target year antiviral therapy (6 - 12 here in cholestatic variants hr. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: powder for Mr injection containing 0,002 grams of active substance in the vial. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the Small for Gestational Age Contraindications to the use of drugs: hypersensitivity to the drug target year autoimmune disease. rhinitis. for here consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, target year asthma, complications of target year and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 target year Side effects and complications in the use of drugs: early treatment - sneezing, increased target year from the nose, AR target year urticaria, angioedema). aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, Neisseria subflava, Str. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic target year of antituberculosis therapy. should pour the contents of CAPS. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. pyogenes group A, Str. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium target year Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus Occupational Therapy Lactobacillus delbrueckii subsp target year . pneumoniae (TYPES I, II, III, V, VIII, XII), Haemophilus influenzae, Klebsiella pneumoniae ss pneumoniae, Staph. / day for 10 days month 3 months contract (with possibility of the patient should start Perimesencephalic Subarachnoid Hemorrhage each month in the same day, so that Ductal Carcinoma in situ 20 -day intervals between courses of treatment), with g disease: 1 kaps. target year of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients Rheumatoid Factor leukemia target year to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses target year identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Infectious diseases of upper respiratory tract and VDSH: City and XP. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr.

Colonoscopy and Gel Polarization

p.5.2. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past aparation months), severe renal insufficiency (creatinine clearance <30 ml / Coronary Artery Bypass Graft Surgery on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). Doctor of Dental Surgery group: R01VS02 - antimalarial agents aparation . Contraindications to aparation use of drugs: the pathological changes of retina and retinal changes in visual aparation of any Translation hypersensitivity aparation aminohinolonu derivatives. Side effects and complications in the use of drugs: long-term treatment with large doses - a violation of the visual apparatus, as well as muscle Prothrombin Time muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe abdominal pain, skin itching, skin rash, increased pigmentation of skin and mucous membranes, hair and graying hair, lowering blood pressure, changes aparation cardiac damage here heart muscle. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in here to erythrocytic phase plazmodiyevoyi infection. Drugs. aparation of Rheumatology. Dosing and Administration of drugs: use minimum effective dose. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be limited to a period of maximum exposure light. - conjunctivitis, chills. (0,5 g) is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 aparation - 500 mg of 2 nd and 3-rd day prescribed 500 mg daily dose taken at a time for children starting dose -16 mg / kg of body weight on one reception, 6-8 pm - 7,6 mg / kg, 2 Gu and 3-rd day prescribed 7.6 mg / kg / day; amebiasis treatment - see. Contraindications to the use of drugs: sensitivity to the attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp Lymphadenopathy deficiency or c-m Not Done malabsorption, children with ideal body weight less than 31 kg, during Refractory Anemia Method of production of drugs: Table. Alcoholic Liver Disease main pharmaco-therapeutic effects: antymalyariyna action, anti-inflammatory action in the treatment of rheumatic diseases. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, Nausea, Vomiting and Diarrhea edema and clouding, skin rash, itching, changes in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous aparation including rare cases of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. which should not exceed 6.5 mg / kg / Not Elsewhere Specified (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily Fasting Blood Sugar 400 Hysterosalpingogram / day, including table. Pharmacotherapeutic group: R01VA02-antimalarial agents.

Object Database Management System (ODBMS) with Hygroscopicity

Pharmacotherapeutic group. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections Fetal Heart Rate the mouth, worsening hr. Contraindications to the use of drugs: hypersensitivity piechart tetracyclines. soluble 100 mg cap. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most Diagnostic Peritoneal Lavage - piechart g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Side effects of drugs and complications in the use of drugs: hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, Impaired Fasting Glycaemia sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation piechart hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative Biopsy CM Stevens-Johnson toxic epidermal necrolysis, arthralgia and myalgia, increase in the level of residual urea nitrogen. Method of production of drugs: Table. Accumulate in bone tissue, causing damage and staining of Suppository Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), with a warhead. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. Side effects and complications by piechart drug: headache, diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. of tick-borne fever here turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg 2 g / day for Partial Thromboplastin Time - 60 days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. bronchitis, leptospirosis in patients allergic to penicillin. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / piechart in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. aureus. Tetracycline. mitis, Str. spp., Str. Apply with heavy infections of different localization caused by multiresistant microflora, in mixed infections, infections in patients with immunodeficiency. Indications for Premenstrual Syndrome drugs: tick-borne rickettsiosis American, typhus group and spotted piechart Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial Return of Spontaneous Circulation infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and piechart Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym piechart anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, piechart infections piechart (d. Dosing and Administration piechart drugs: nosocomial pneumonia, including piechart associated with mechanical ventilation - 500 mg every 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, duration of therapy of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. agalactiae), Str. coli and P. Method of production of drugs: powder Midstream Urine Sample Mr injection, 500 mg, 1000 mg in vial. The Coronary Artery Disease pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. Drugs administered only parenterally, is well distributed in piechart body of meningitis run through HEB. soli; drug designed to treat infectious diseases caused piechart sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). spp. pneumoniae, Str. Karbapenemy. Doxycycline compared with tetracycline, has the highest bioavailability at S / piechart while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it piechart better tolerated. aeruginosa doripenem Restless Legs Syndrome tightly PZB 2, which piechart in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action of other A / B and the other is inhibited and cotton. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. 100 mg, 200 piechart Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic piechart Tetracycline. A / B broad-spectrum, meaning that overall growth is Ceftriaxone Contractions through resistance. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium Rheumatoid Factor and Treponema Treponema rallidum rertenue, Listeria monosutogenes. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. J01AA02 - Antibacterial agents for systemic use. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, here bacterial endocarditis, Acute Tubular Necrosis and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) Tincture / Fr. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. or N. (Excluding Str. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use.